Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Strategies to Improve Well-Being and Diabetes Management
This project aims to implement an adapted self-affirmation intervention among a population of individuals with diabetes to reduce the negative psychosocial impacts of stigma. In a self-affirmation, participants are guiding through a writing exercise writing designed to reinforce sources of self-worth before they encounter or engage in stressful or stigmatizing events. Participants in this study will be asked to complete self-affirmation exercises before their 3-month wellness appointments with their endocrinologists over the course of a year. The main questions the investigators are asking are: - Will self-affirmation reduce feelings of stigmatization? - Will self-affirmation increase self-efficacy and motivation to engage in condition management behaviors. - Will self-affirmation improve blood glucose control. Participants will be randomly assigned to either the intervention condition or a waitlist control condition. Participants in the waitlist control condition will also complete writing exercises but they will be abbreviated (this in the psychological literature is referred to as a "low affirmation condition"). At the end of the study, waitlist control participants will have access to the full exercise should they like to receive it. After each appointment and self-affirmation, participants will complete surveys assessing feelings of stigma and motivation to engage in condition management. All participants will already be using continuous glucose monitors. The investigators will compare both survey responses and continuous glucose data between our conditions to assess the efficacy of the self-affirmation intervention.
| Status | Not yet recruiting |
| Enrollment | 150 |
| Est. completion date | February 28, 2027 |
| Est. primary completion date | March 28, 2026 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Participants must be at least 18 years of age, have a type 2 diabetes (T2D) diagnosis, and currently use a continue glucose monitor as part of their condition management. Exclusion Criteria: - Individuals under 18 years of age |
| Country | Name | City | State |
|---|---|---|---|
| United States | MaineHealth Institute for Research, Center for Interdisciplinary and Population Health Research | Westbrook | Maine |
| Lead Sponsor | Collaborator |
|---|---|
| Elizabeth Scharnetzki | MaineHealth Institute for Research |
United States,
American Diabetes Association (2022, July 28). Statistics About Diabetes. Retrieved April 8, 2023, from https://diabetes.org/about-us/statistics/about-diabetes#:~:text=Prevalence%20in%20seniors%3A%20The%20percentage,diagnosed%20with%20diabetes%20every%20year.
American Psychological Association. (n.d.). APA Dictionary of Psychology. American Psychological Association. https://dictionary.apa.org/wait-list-control-group
Armitage CJ, Harris PR, Hepton G, Napper L. Self-affirmation increases acceptance of health-risk information among UK adult smokers with low socioeconomic status. Psychol Addict Behav. 2008 Mar;22(1):88-95. doi: 10.1037/0893-164X.22.1.88. — View Citation
Bayer R. Stigma and the ethics of public health: not can we but should we. Soc Sci Med. 2008 Aug;67(3):463-72. doi: 10.1016/j.socscimed.2008.03.017. Epub 2008 May 24. — View Citation
Browne JL, Ventura AD, Mosely K, Speight J. Measuring the Stigma Surrounding Type 2 Diabetes: Development and Validation of the Type 2 Diabetes Stigma Assessment Scale (DSAS-2). Diabetes Care. 2016 Dec;39(12):2141-2148. doi: 10.2337/dc16-0117. Epub 2016 Aug 11. Erratum In: Diabetes Care. 2017 Jun;40(6):808. — View Citation
Centers for Disease Control and Prevention (2022, June 29). National Diabetes Statistics Report Estimates of Diabetes and Its Burden in the United States. Retrieved April 8, 2023, from https://www.cdc.gov/diabetes/data/statistics-report/index.html
Centers for Disease Control and Prevention. (2002). About Prediabetes & Type 2 Diabetes. Retrieved from https://www.cdc.gov/diabetes/prevention/about-prediabetes.html
Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A View Beyond HbA1c: Role of Continuous Glucose Monitoring. Diabetes Ther. 2019 Jun;10(3):853-863. doi: 10.1007/s13300-019-0619-1. Epub 2019 Apr 29. — View Citation
Cohen GL, Garcia J, Apfel N, Master A. Reducing the racial achievement gap: a social-psychological intervention. Science. 2006 Sep 1;313(5791):1307-10. doi: 10.1126/science.1128317. — View Citation
Cohen GL, Garcia J, Purdie-Vaughns V, Apfel N, Brzustoski P. Recursive processes in self-affirmation: intervening to close the minority achievement gap. Science. 2009 Apr 17;324(5925):400-3. doi: 10.1126/science.1170769. — View Citation
Cohen GL, Sherman DK. The psychology of change: self-affirmation and social psychological intervention. Annu Rev Psychol. 2014;65:333-71. doi: 10.1146/annurev-psych-010213-115137. — View Citation
Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd Edn. New York, NY: Academic Press.
Epton T, Harris PR, Kane R, van Koningsbruggen GM, Sheeran P. The impact of self-affirmation on health-behavior change: a meta-analysis. Health Psychol. 2015 Mar;34(3):187-96. doi: 10.1037/hea0000116. Epub 2014 Aug 18. — View Citation
Epton T, Harris PR. Self-affirmation promotes health behavior change. Health Psychol. 2008 Nov;27(6):746-52. doi: 10.1037/0278-6133.27.6.746. — View Citation
Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91. doi: 10.3758/bf03193146. — View Citation
Ferrer RA, Cohen GL. Reconceptualizing Self-Affirmation With the Trigger and Channel Framework: Lessons From the Health Domain. Pers Soc Psychol Rev. 2019 Aug;23(3):285-304. doi: 10.1177/1088868318797036. Epub 2018 Oct 7. — View Citation
Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013 May;103(5):813-21. doi: 10.2105/AJPH.2012.301069. Epub 2013 Mar 14. — View Citation
Himmelstein MS, Puhl RM. At multiple fronts: Diabetes stigma and weight stigma in adults with type 2 diabetes. Diabet Med. 2021 Jan;38(1):e14387. doi: 10.1111/dme.14387. Epub 2020 Sep 23. — View Citation
Hoyt CL, Burnette JL, Thomas FN, Orvidas K. Public Health Messages and Weight-Related Beliefs: Implications for Well-Being and Stigma. Front Psychol. 2019 Dec 17;10:2806. doi: 10.3389/fpsyg.2019.02806. eCollection 2019. — View Citation
Hunger JM, Major B, Blodorn A, Miller CT. Weighed down by stigma: How weight-based social identity threat contributes to weight gain and poor health. Soc Personal Psychol Compass. 2015 Jun;9(6):255-268. doi: 10.1111/spc3.12172. Epub 2015 Jun 4. — View Citation
Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17. doi: 10.3352/jeehp.2021.18.17. Epub 2021 Jul 30. — View Citation
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. — View Citation
Kroeper, K. M., Williams, H. E., Thompson, S., Hernandez-Colmenares, A., Mills, A., Spencer, S. J., & Murphy, M. C. (in progress). The Social Identity Threat Concerns Scale [data analysis and writing ongoing].
Lee KM, Hunger JM, Tomiyama AJ. Weight stigma and health behaviors: evidence from the Eating in America Study. Int J Obes (Lond). 2021 Jul;45(7):1499-1509. doi: 10.1038/s41366-021-00814-5. Epub 2021 May 1. — View Citation
Liu NF, Brown AS, Folias AE, Younge MF, Guzman SJ, Close KL, Wood R. Stigma in People With Type 1 or Type 2 Diabetes. Clin Diabetes. 2017 Jan;35(1):27-34. doi: 10.2337/cd16-0020. Erratum In: Clin Diabetes. 2017 Oct;35(4):262. Folias AE [added]. — View Citation
Major B, O'Brien LT. The social psychology of stigma. Annu Rev Psychol. 2005;56:393-421. doi: 10.1146/annurev.psych.56.091103.070137. — View Citation
Major, B., Hunger, J. M., Bunyan, D. P., & Miller, C. T. (2014). The ironic effects of weight stigma. Journal of Experimental Social Psychology, 51, 74-80. https://doi.org/10.1016/j.jesp.2013.11.009
Meadows A, Higgs S. The Multifaceted Nature of Weight-Related Self-Stigma: Validation of the Two-Factor Weight Bias Internalization Scale (WBIS-2F). Front Psychol. 2019 Apr 16;10:808. doi: 10.3389/fpsyg.2019.00808. eCollection 2019. — View Citation
Miyake A, Kost-Smith LE, Finkelstein ND, Pollock SJ, Cohen GL, Ito TA. Reducing the gender achievement gap in college science: a classroom study of values affirmation. Science. 2010 Nov 26;330(6008):1234-7. doi: 10.1126/science.1195996. — View Citation
Muraven M, Baumeister RF. Self-regulation and depletion of limited resources: does self-control resemble a muscle? Psychol Bull. 2000 Mar;126(2):247-59. doi: 10.1037/0033-2909.126.2.247. — View Citation
Pinel EC. Stigma consciousness: the psychological legacy of social stereotypes. J Pers Soc Psychol. 1999 Jan;76(1):114-28. doi: 10.1037//0022-3514.76.1.114. — View Citation
Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE. Assessment of diabetes-related distress. Diabetes Care. 1995 Jun;18(6):754-60. doi: 10.2337/diacare.18.6.754. — View Citation
Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005 Oct;28(10):2543-5. doi: 10.2337/diacare.28.10.2543. No abstract available. — View Citation
Puhl RM, Heuer CA. Obesity stigma: important considerations for public health. Am J Public Health. 2010 Jun;100(6):1019-28. doi: 10.2105/AJPH.2009.159491. Epub 2010 Jan 14. — View Citation
Puhl RM, Himmelstein MS, Hateley-Browne JL, Speight J. Weight stigma and diabetes stigma in U.S. adults with type 2 diabetes: Associations with diabetes self-care behaviors and perceptions of health care. Diabetes Res Clin Pract. 2020 Oct;168:108387. doi: 10.1016/j.diabres.2020.108387. Epub 2020 Aug 26. — View Citation
Puhl RM, Himmelstein MS, Pearl RL. Weight stigma as a psychosocial contributor to obesity. Am Psychol. 2020 Feb-Mar;75(2):274-289. doi: 10.1037/amp0000538. — View Citation
Puhl RM, Latner JD, King KM, Luedicke J. Weight bias among professionals treating eating disorders: attitudes about treatment and perceived patient outcomes. Int J Eat Disord. 2014 Jan;47(1):65-75. doi: 10.1002/eat.22186. Epub 2013 Sep 5. — View Citation
Ritholz MD, Smaldone A, Lee J, Castillo A, Wolpert H, Weinger K. Perceptions of psychosocial factors and the insulin pump. Diabetes Care. 2007 Mar;30(3):549-54. doi: 10.2337/dc06-1755. — View Citation
Saguy AC, Frederick D, Gruys K. Reporting risk, producing prejudice: how news reporting on obesity shapes attitudes about health risk, policy, and prejudice. Soc Sci Med. 2014 Jun;111:125-33. doi: 10.1016/j.socscimed.2014.03.026. Epub 2014 Mar 28. — View Citation
Schabert J, Browne JL, Mosely K, Speight J. Social stigma in diabetes : a framework to understand a growing problem for an increasing epidemic. Patient. 2013;6(1):1-10. doi: 10.1007/s40271-012-0001-0. — View Citation
Schmader T, Johns M, Forbes C. An integrated process model of stereotype threat effects on performance. Psychol Rev. 2008 Apr;115(2):336-56. doi: 10.1037/0033-295X.115.2.336. — View Citation
Schmitt A, Kulzer B, Ehrmann D, Haak T, Hermanns N. A Self-Report Measure of Diabetes Self-Management for Type 1 and Type 2 Diabetes: The Diabetes Self-Management Questionnaire-Revised (DSMQ-R) - Clinimetric Evidence From Five Studies. Front Clin Diabetes Healthc. 2022 Jan 13;2:823046. doi: 10.3389/fcdhc.2021.823046. eCollection 2021. — View Citation
Shapiro JR, Neuberg SL. From stereotype threat to stereotype threats: implications of a multi-threat framework for causes, moderators, mediators, consequences, and interventions. Pers Soc Psychol Rev. 2007 May;11(2):107-30. doi: 10.1177/1088868306294790. — View Citation
Shapiro JR. Different groups, different threats: a multi-threat approach to the experience of stereotype threats. Pers Soc Psychol Bull. 2011 Apr;37(4):464-80. doi: 10.1177/0146167211398140. — View Citation
Sherman DK, Hartson KA, Binning KR, Purdie-Vaughns V, Garcia J, Taborsky-Barba S, Tomassetti S, Nussbaum AD, Cohen GL. Deflecting the trajectory and changing the narrative: how self-affirmation affects academic performance and motivation under identity threat. J Pers Soc Psychol. 2013 Apr;104(4):591-618. doi: 10.1037/a0031495. Epub 2013 Feb 11. — View Citation
Sherman, D. A. K., Nelson, L. D., & Steele, C. M. (2000). Do messages about health risks threaten the self? Increasing the acceptance of threatening health messages via self-affirmation. Personality and Social Psychology Bulletin, 26(9), 1046-1058. https://doi.org/10.1177/01461672002611003
Sherman, D. A., Nelson, L. D., & Steele, C. M. (2000). Do messages about health risks threaten the self? Increasing the acceptance of threatening health messages via self-affirmation. Personality and Social Psychology Bulletin, 26(9), 1046-1058.
Sherman, D. K., & Cohen, G. L. (2006). The psychology of self-defense: Self-affirmation theory. In M. P. Zanna (Ed.), Advances in experimental social psychology, Vol. 38, pp. 183-242). Elsevier Academic Press. https://doi.org/10.1016/S0065-2601(06)38004-5
Sherman, D. K., Lokhande, M., Müller, T., & Cohen, G. L. (2021). Self affirmation interventions. In G. M. Walton & A. J. Crum (Eds.), Handbook of wise interventions: How social psychology can help people change (pp. 63-99). The Guilford Press.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092. — View Citation
Stangl AL, Earnshaw VA, Logie CH, van Brakel W, C Simbayi L, Barre I, Dovidio JF. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019 Feb 15;17(1):31. doi: 10.1186/s12916-019-1271-3. — View Citation
Steele CM. A threat in the air. How stereotypes shape intellectual identity and performance. Am Psychol. 1997 Jun;52(6):613-29. doi: 10.1037//0003-066x.52.6.613. — View Citation
Steele, C. M. (1988). The psychology of self-affirmation: Sustaining the integrity of the self. In L. Berkowitz (Ed.), Advances in experimental social psychology, Vol. 21. Social psychological studies of the self: Perspectives and programs (pp. 261-302). Academic Press.
Steele, C. M., Spencer, S. J., & Aronson, J. (2002). Contending with group image: The psychology of stereotype and social identity threat. In M. P. Zanna (Ed.), Advances in experimental social psychology, Vol. 34, pp. 379-440). Academic Press. https://doi.org/10.1016/S0065-2601(02)80009-0
Swinburn BA, Kraak VI, Allender S, Atkins VJ, Baker PI, Bogard JR, Brinsden H, Calvillo A, De Schutter O, Devarajan R, Ezzati M, Friel S, Goenka S, Hammond RA, Hastings G, Hawkes C, Herrero M, Hovmand PS, Howden M, Jaacks LM, Kapetanaki AB, Kasman M, Kuhnlein HV, Kumanyika SK, Larijani B, Lobstein T, Long MW, Matsudo VKR, Mills SDH, Morgan G, Morshed A, Nece PM, Pan A, Patterson DW, Sacks G, Shekar M, Simmons GL, Smit W, Tootee A, Vandevijvere S, Waterlander WE, Wolfenden L, Dietz WH. The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report. Lancet. 2019 Feb 23;393(10173):791-846. doi: 10.1016/S0140-6736(18)32822-8. Epub 2019 Jan 27. No abstract available. Erratum In: Lancet. 2019 Feb 23;393(10173):746. — View Citation
Talumaa B, Brown A, Batterham RL, Kalea AZ. Effective strategies in ending weight stigma in healthcare. Obes Rev. 2022 Oct;23(10):e13494. doi: 10.1111/obr.13494. Epub 2022 Aug 7. — View Citation
Vadiveloo M, Mattei J. Perceived Weight Discrimination and 10-Year Risk of Allostatic Load Among US Adults. Ann Behav Med. 2017 Feb;51(1):94-104. doi: 10.1007/s12160-016-9831-7. Erratum In: Ann Behav Med. 2017 Feb;51(1):105. — View Citation
Van Der Ven NC, Weinger K, Yi J, Pouwer F, Ader H, Van Der Ploeg HM, Snoek FJ. The confidence in diabetes self-care scale: psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and US patients with type 1 diabetes. Diabetes Care. 2003 Mar;26(3):713-8. doi: 10.2337/diacare.26.3.713. — View Citation
van Koningsbruggen GM, Das E. Don't derogate this message! Self-affirmation promotes online type 2 diabetes risk test taking. Psychol Health. 2009 Jul;24(6):635-49. doi: 10.1080/08870440802340156. — View Citation
Walton GM, Cohen GL. A brief social-belonging intervention improves academic and health outcomes of minority students. Science. 2011 Mar 18;331(6023):1447-51. doi: 10.1126/science.1198364. — View Citation
Wu YK, Berry DC. Impact of weight stigma on physiological and psychological health outcomes for overweight and obese adults: A systematic review. J Adv Nurs. 2018 May;74(5):1030-1042. doi: 10.1111/jan.13511. Epub 2017 Dec 8. — View Citation
* Note: There are 61 references in all — Click here to view all references
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Social Identity Threat Concerns (SITC) Scale | Used to assess participants' concerns about experiencing stigma-induced identity threat while receiving care for T2D. A 1 (Strongly disagree) to 7 (Strongly agree) Likert response scale is used for all items. A composite score is created by summing all items. Higher values indicate greater social identity threat concerns. | Immediately after each intervention; completed 4 times over the course of a year | |
| Primary | Two-Factor Weight Bias Internalization Scale | 6-item subscale measure assessing weight-related self-devaluation. . A 1 (Strongly disagree) to 7 (Strongly agree) Likert response scale is used for all items. A composite score is created by summing all items. Higher values indicate greater weight bias internalization. | Immediately after each intervention; completed 4 times over the course of a year | |
| Primary | Diabetes Stigma Assessment Scale | 6-item subscale assessing participants perceived and experienced stigma for use with adults with diabetes. A 1(strongly disagree) to 5 (strongly agree) Likert response scale is used for all items. A composite score is created by summing all items. Higher values indicate greater diabetes stigma. | Immediately after each intervention; completed 4 times over the course of a year | |
| Primary | The Revised Diabetes Self-Management Questionnaire | 27-items measure to assess uptake of essential self-management practices for Diabetes. A 0 (Does not apply to me) to 3 (Applies to me very much) Likert response scale is used for all items. | Immediately after each intervention; completed 4 times over the course of a year | |
| Primary | Confidence in Diabetes Self-Care Scale | 20-item measure assessing patient self-efficacy, confidence in ability to perform diabetes self-care tasks. A 1 ("No, I am sure I cannot") to 5 ("Yes, I am sure I can") Likert response scale is used for all items. A composite score is created by summing all items. Higher values indicate greater confidence. | Immediately after each intervention; completed 4 times over the course of a year | |
| Primary | Blood glucose | Continuous glucose monitor derived indices for time spent in-range | Through study completion, an average of 1 year | |
| Secondary | Hemoglobin A1C | Blood assay assessing average blood glucose level; Will be collected as part of EPIC data requests; HbA1c will be requested at the time of study enrollment and throughout study completion (5 total) | Collected once at time of study enrollment and once at study completion | |
| Secondary | Patient-reported age | Patient's self-reported age in years | Collected once at time of study enrollment | |
| Secondary | Patient Gender | Patient's self-reported gender identity; They may select as many as apply from the following: Man, Woman, Transgender, Gender Queer/Gender non-conforming, Non-Binary, Different Identity (Please specify), Prefer not to answer | Collected once at time of study enrollment | |
| Secondary | Patient Race | Patient's self-reported racial identity. They may select as many as apply from the following: White, Black, Asian, Native American or Alaska Native, Middle Eastern or North African, Native Hawaiian or other Pacific Islander Different Identity(Please specify) Prefer not to answer | Collected once at time of study enrollment | |
| Secondary | Patient ethnicity | Patient's self-reported ethnicity: Are you of Hispanic, Latino or Spanish origin, such as Mexican, Puerto Rican, or Cuban? Yes, No, Prefer not to answer | Collected once at time of study enrollment | |
| Secondary | Patient's highest level of education completed | Patient's self-reported highest level of education completed; They may select from:
8th grade or less, Some high school, High school diploma/GED, Some college or technical school classes, no degree, Associate's or Bachelor's degree, Master's, doctorate, or professional degree, Prefer not to answer |
Collected once at time of study enrollment | |
| Secondary | Household income | Patient's self-reported household income: Which of the following categories best describes the total income for the household where you live?
Less than $20,000 Between $20,000 and $70,000 More than $70,000 Don't know/Not sure Prefer not to answer |
Collected once at time of study enrollment | |
| Secondary | Zip code | Patients will be asked to provide a value for the following question: What is the zip code for the area where you currently live? Zip codes will be converted to Rural-Urban Commuting Area Codes, which are used to classify census tracts into rural and urban categories. | Collected once at time of study enrollment | |
| Secondary | Years since diagnosis | Patients' will provide a value for the following question: How many years has it been since you were first diagnosed with Type 2 Diabetes?
Diabetes diagnosis and year of diabetes diagnosis will also be verified as part of an EPIC data request |
Collected once at time of study enrollment | |
| Secondary | Diabetes Management Plan | Patients' will provide a value for the following question: Which of the following options best describes how you manage your Type 2 Diabetes?
Diet Medication Both diet and medication If Medication or Both diet and medication is selected: Please tell us more about medications and medication dosages you are currently taking to manage your diabetes: ______________________ |
Collected once at time of study enrollment | |
| Secondary | Physical activity | Patients' will provide text responses for the following questions:
What kind of physical activity do you do? How often do you do this activity (days per week) How long do you typically do this activity for (minutes) |
Collected once at time of study enrollment | |
| Secondary | Continuous glucose monitor use | Patients' will provide a value for the following question:
How long have you been using your continuous glucose monitor (in months or years)? |
Collected once at time of study enrollment | |
| Secondary | Height | Patient's height (feet and inches) will be collected as part of an EPIC data request; this will be used to calculate BMI | Collected once at time of study enrollment | |
| Secondary | Weight | Patient's weight (pounds) will be collected as part of an EPIC data request; this will be used to calculate BMI | Collected once at time of study enrollment | |
| Secondary | History of weight-based victimization (moderator/covariate) | 3-item measure assessing experiences of weight-based discrimination. A binary Yes/No response scale is used for all items. The number of affirmative responses will be summed to create a composite. Higher scores indicate greater weight-based victimization. | Collected once at time of study enrollment | |
| Secondary | Problem Areas in Diabetes Questionnaire (moderator/covariate) | 20-item measure of diabetes-related emotional distress that assesses a broad range of feelings related to living with diabetes. A 0 (Not a problem) to 4 (Serious problem) Likert response scale is used for all items. A composite score is created by summing all items. Higher values indicate greater distress. | Collected once at time of study enrollment | |
| Secondary | Generalized Anxiety Disorder 7-item (moderator/covariate) | 7-item measure of generalized anxiety disorder. A 0 (Not at all) to 3 (Nearly every day) Likert response scale is used for all items. A composite score is created by summing all items. Higher values indicate greater anxiety. | Collected once at time of study enrollment | |
| Secondary | Patient Health Questionnaire (PHQ-9) (moderator/covariate) | 9-item measure of depression severity. A 0 (Not at all) to 3 (Nearly every day) Likert response scale is used for all items. A composite score is created by summing all items. Higher values indicate greater depression. | Collected once at time of study enrollment | |
| Secondary | Stigma Consciousness Questionnaire (moderator/covariate) | 10-item measure to predict the degree to which stigmatized groups expect to be stereotyped and discriminated against by others. These items will be adapted to measure stigma consciousness relating to diabetes and health care. A 0 (strongly disagree) to 6(strongly agree) Likert scale, with a midpoint of 3 (neither agree nor disagree) is used for all items. A composite score is created by summing all items. Higher values indicate greater stigma consciousness. | Collected once at time of study enrollment |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |